Market capitalization | CHF17.81b |
Enterprise Value | CHF19.11b |
P/E (TTM) P/E ratio | 29.64 |
EV/FCF (TTM) EV/FCF | 29.56 |
EV/Sales (TTM) EV/Sales | 5.27 |
P/S ratio (TTM) P/S ratio | 4.91 |
P/B ratio (TTM) P/B ratio | 7.21 |
Dividend yield | 1.44% |
Last dividend (FY24) | CHF4.30 |
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
18 Analysts have issued a Sonova forecast:
18 Analysts have issued a Sonova forecast:
Mar '24 |
+/-
%
|
||
Revenue | 3,627 3,627 |
3%
3%
|
|
Gross Profit | 2,564 2,564 |
1%
1%
|
|
EBITDA | 940 940 |
6%
6%
|
EBIT (Operating Income) EBIT | 694 694 |
9%
9%
|
Net Profit | 601 601 |
7%
7%
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sonova Holding AG engages in the manufacture of hearing care solutions. It operates through Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment t includes the activities of the design, development, manufacture, distribution and service of hearing instruments and related products. The Cochlear Implants segment includes the activities of the design, development, manufacture, distribution and service of hearing implants and related products. Its products include Phonak, Unitron, Connect Hearing, and Advanced Bionics. The company was founded by Andreas E. Rihs, Beda Diethelm, and Hans-Ueli Rihs in 1985 and is headquartered in Stafa, Switzerland.
Head office | Switzerland |
CEO | Arnd Kaldowski |
Employees | 18,151 |
Founded | 1947 |
Website | www.sonova.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.